• Home
  • News
  • Fortune 500
  • Tech
  • Finance
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
oxycontin

Family Behind Purdue Pharma and OxyContin Faces Multiple Lawsuits

By
Renae Reints
Renae Reints
Down Arrow Button Icon
By
Renae Reints
Renae Reints
Down Arrow Button Icon
November 19, 2018, 4:07 PM ET

The Sackler family—members of which own Purdue Pharma, maker of the legal but highly addictive prescription painkiller OxyContin—is facing several lawsuits and a possible criminal investigation for its role in the opioid crisis, The Guardian reports.

Last month, New York’s Suffolk County filed a lawsuit that names eight Sackler family members across three generations who serve or have served on Purdue’s board. The lawsuit said the Sacklers “actively participated in conspiracy and fraud to portray the prescription painkiller as non-addictive, even though they knew it was dangerously addictive.”

The family has a net worth of $13 billion, according to Forbes.

“This is essentially a crime family … drug dealers in nice suits and dresses,” Paul Hanly, a New York City lawyer representing Suffolk County, told The Guardian. “What Purdue Pharma and the Sackler family have done to society through their aggressive peddling of opioids is unconscionable.”

In a statement to Fortune, Purdue Pharma said The Guardian‘s article “presents an inaccurate view of this complex legal matter,” adding that the “disinformation and ad hominem personal attacks” being put forth by the plaintiffs’ counsel only undermines real efforts to combat the opioid crisis, a “serious and complex public health problem.”

“The article relies heavily on comments from two contingency fee lawyers who are suing the Company for their own gain and who are willing to recklessly smear the reputations of companies and individuals in order to extract money in litigation,” the Purdue Pharma statement said of The Guardian‘s article. “Plaintiffs’ effort to name individual members of the Sackler family as defendants in the ongoing civil litigation is misguided and contradicts well established principles of law. These suits will be vigorously contested.”

Purdue Pharma and other opioid manufacturers are entangled in lawsuits across the country, with Purdue alone facing litigation from 30 states, according to The Guardian. In a 2007 case, Purdue executives unrelated to the Sacklers pleaded guilty to misleading doctors about OxyContin’s potential for abuse, resulting in Purdue paying out $600 million in fines.

Since then, the opioid crisis has only grown, with a record of nearly 72,000 people dying of drug overdose in 2017 alone.

Now, the family itself is facing a series of court battles. Along with the Suffolk County case, the Sacklers were sued by Massachusetts in June.

“For them it’s greed, it was all about profits over people,” Massachusetts attorney general Maura Healey told The Guardian. “I feel very confident naming the family members.”

The family members are also expected to be named in federal multi-district litigation in Ohio, and a source told The Guardian the family is also named in ongoing criminal investigations at the federal level. The Sacklers could not immediately be reached for comment.

Update: A statement from Purdue Pharma was added to this article after its initial publication.

About the Author
By Renae Reints
See full bioRight Arrow Button Icon

Latest in

CybersecuritySmall Business
Main Street’s make-or-break upgrade: Why small businesses are racing to modernize their tech
By Ashley LutzDecember 3, 2025
9 minutes ago
MagazineMarkets
Why an AI bubble could mean chaos for stock markets—and how smart investors are protecting their portfolios
By Alyson ShontellDecember 3, 2025
19 minutes ago
SuccessThe Promotion Playbook
L’Oreal CHRO cut her teeth at luxury brands Chanel and Kiehl’s—like Walmart’s CEO she says the secret to her success was always saying yes
By Orianna Rosa RoyleDecember 3, 2025
39 minutes ago
Personal Financegold prices
Current price of gold as of December 3, 2025
By Danny BakstDecember 3, 2025
56 minutes ago
Rakesh Kumar
CommentarySemiconductors
China does not need Nvidia chips in the AI war — export controls only pushed it to build its own AI machine
By Ramesh KumarDecember 3, 2025
1 hour ago
Rochelle Witharana is Chief Financial and Investment Officer for The California Wellness Foundation
Commentarydiversity and inclusion
Fund managers from diverse backgrounds are delivering standout returns and the smart money is slowly starting to pay attention
By Rochelle WitharanaDecember 3, 2025
1 hour ago

Most Popular

placeholder alt text
Economy
Ford workers told their CEO 'none of the young people want to work here.' So Jim Farley took a page out of the founder's playbook
By Sasha RogelbergNovember 28, 2025
5 days ago
placeholder alt text
North America
Jeff Bezos and Lauren Sánchez Bezos commit $102.5 million to organizations combating homelessness across the U.S.: ‘This is just the beginning’
By Sydney LakeDecember 2, 2025
24 hours ago
placeholder alt text
Success
Warren Buffett used to give his family $10,000 each at Christmas—but when he saw how fast they were spending it, he started buying them shares instead
By Eleanor PringleDecember 2, 2025
1 day ago
placeholder alt text
Economy
Elon Musk says he warned Trump against tariffs, which U.S. manufacturers blame for a turn to more offshoring and diminishing American factory jobs
By Sasha RogelbergDecember 2, 2025
22 hours ago
placeholder alt text
C-Suite
MacKenzie Scott's $19 billion donations have turned philanthropy on its head—why her style of giving actually works
By Sydney LakeDecember 2, 2025
1 day ago
placeholder alt text
North America
Anonymous $50 million donation helps cover the next 50 years of tuition for medical lab science students at University of Washington
By The Associated PressDecember 2, 2025
1 day ago
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.